| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d052cb03475895a2eb49fa0ed9516995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df2ad9bdccfe6fb34159303f83a10744 |
| publicationDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002165263-A1 |
| titleOfInvention |
Treatment of fibromyalgia and related fatigue syndromes using antagonists or paritcal agonists of 5HT1a receptors |
| abstract |
The present invention provides a method for treating fibromyalgia and/or chronic fatigue syndrome by administering an antagonist or partial agonist of 5HT1 a receptors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8835485-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008262071-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010125348-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006030306-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010511685-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102438603-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006030306-A3 |
| priorityDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |